Cipla Limited is an Indian multinational pharmaceutical and biotechnology company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions. Read More
Pharmaceutical firm Eli Lilly and Cipla entered into a strategic partnership in India to enhance access to Lilly's key diabetes products on Monday. ...
India Ratings and Research (Ind-Ra) said on Tuesday that 13.7 per cent y-o-y revenue growth in India's pharmaceutical market during 2021 was led by continued demand normalisation post the high growth months of April and May. ...
Even as the US giant drug maker Moderna's COVID-19 messenger RNA (mRNA) vaccine is expected to reach India this week, discussions are still going on over indemnity waiver, informed sources. ...
India Ratings and Research (Ind-Ra) has said the 14.1 per cent y-o-y growth in pharmaceutical market during June was led by a normalisation of demand post high growth months of April (51.5 per cent) and May (47.8 per cent). ...
US biotechnology company Moderna on Tuesday announced that India has granted permission for its COVID-19 vaccine to be imported into the country for restricted use in an emergency situation. ...
